Last $33.53 USD
Change Today +0.33 / 0.99%
Volume 330.9K
MYGN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:10 PM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Dale A. Stringfellow Ph.D.

Former Chairman, Member of Audit Committee and Member of Compensation Committee, Myriad Genetics Inc.
AgeTotal Calculated CompensationThis person is connected to 4 board members in 1 different organizations across 4 different industries.

See Board Relationships
69--

Background*

Dr. Dale A. Stringfellow is a Director Emeritus at Golden Pine Ventures, LLC. He was the Chairman of the Board of Collateral Therapeutics and Director since 1999. Dr. Stringfellow served as the Chairman of the Board of Myriad Genetics Inc., since December 4, 2003 to March 18, 2005 and Director from December 1991 to March 18, 2005, and was a Member of Audit and Compensation Committees. From July 1990 to April 1995, he served as a Director at Celtrix Pharmaceuticals. Dr. ...

Read Full Background

Corporate Headquarters*

320 Wakara Way
Salt Lake City, Utah 84108

United States

Phone: 801-584-3600
Fax: 801-584-3640

Board Members Memberships*

Former Director
Director Emeritus
1991-2005
Former Chairman, Member of Audit Committee and Member of Compensation Committee
1999-N/A
Former Director

Education*

PhD
The University of Utah
BS
The University of Utah

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MYGN:US $33.53 USD +0.33

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Joseph A. Chlapaty Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Advanced Drainage Systems, Inc.
$454.2K
Marc D. Grodman M.D.Founder, Chairman, Chief Executive Officer, President and Managing Director
Bio-Reference Laboratories Inc.
$1.2M
Russell Cummings Chief Executive Officer, Executive Director and Member of Investment Committee
Imperial Innovations Group plc
403.0K GBP
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$600.0K
Michael J. Pellini M.D., MBAChief Executive Officer, President and Director
Foundation Medicine, Inc.
$403.9K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MYRIAD GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.